JCR Pharmaceuticals Co., Ltd. (TYO:4552)

Japan flag Japan · Delayed Price · Currency is JPY
620.00
+24.00 (4.03%)
Mar 5, 2026, 3:30 PM JST
Market Cap72.70B +23.6%
Revenue (ttm)37.55B +7.2%
Net Income-2.44B
EPS-20.00
Shares Out121.99M
PE Ration/a
Forward PE41.11
Dividend20.00 (3.17%)
Ex-Dividend DateMar 30, 2026
Volume600,000
Average Volume637,775
Open629.00
Previous Close596.00
Day's Range612.00 - 630.00
52-Week Range386.00 - 824.00
Beta0.00
RSI32.15
Earnings DateMay 8, 2026

About JCR Pharmaceuticals

JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The comp... [Read more]

Sector Healthcare
Founded 1975
Employees 987
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4552
Full Company Profile

Financial Performance

Financial Statements